
Shandong
300583.SZShandong Sito Bio-technology Co., Ltd. Price (300583.SZ)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
182,415,980
(6.6291)%Revenue and Profitability
Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 11,031,565 | 283,587,947 | 521,011,426 | 668,166,780 | 568,245,934 | 785,566,458 | 1,052,277,111 | 965,800,380 | 913,187,604 | 1,202,622,703 | 1,312,111,843 | 1,279,783,092 |
Net Income | -1,493,048 | 41,561,599 | 165,754,384 | 187,044,570 | 101,176,690 | 92,001,754 | 126,848,545 | 55,309,472 | -179,807,243 | 36,205,360 | 41,967,413 | 45,603,990 |
FCF USD | -40,869,341 | -21,602,059 | -54,926,092 | -43,564,219 | -45,720,017 | -64,444,475 | -555,274,737 | -153,117,983 | 12,002,866 | -161,570,980 | 1,659,020 | -186,904,791 |
OCF USD | -30,504,100 | 24,949,239 | 174,489,331 | 87,103,732 | 80,146,755 | 10,896,249 | -334,413,378 | 57,616,516 | 254,600,648 | 227,349,328 | 145,335,684 | -92,845,545 |
Financial Health - DEBT
Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
YTPD | 0.00 | 1.09 | 0.60 | 0.75 | 1.64 | 0.00 | 0.67 | 2.98 | -1.03 | 4.58 | 2.91 | 2.38 |
D/E | 0.00 | 0.76 | 0.46 | 0.42 | 0.40 | 0.09 | 0.27 | 0.41 | 0.40 | 0.40 | 0.41 | 0.37 |
CA/CL | 1.15 | 2.03 | 1.46 | 2.06 | 2.25 | 4.36 | 2.37 | 1.60 | 1.21 | 1.02 | 1.05 | 1.42 |
TA/TL | 2.18 | 1.88 | 2.34 | 2.53 | 2.81 | 6.38 | 3.54 | 2.71 | 2.47 | 2.40 | 2.45 | 2.76 |
Total Debt | 0 | 75,193,200 | 135,000,000 | 200,000,000 | 234,400,000 | 150,000,000 | 494,700,000 | 751,759,157 | 658,063,150 | 671,171,427 | 699,951,704 | 742,603,643 |
Management Performance
Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ROIC | -4.60% | 23.43% | 38.27% | 25.91% | 11.20% | 4.59% | 5.37% | 1.93% | -7.82% | 1.52% | 1.78% | 1.03% |
ROE | -4.60% | 42.05% | 57.00% | 39.09% | 17.45% | 5.44% | 7.01% | 3.02% | -10.94% | 2.15% | 2.44% | 2.27% |
ROA | 0.00% | 19.73% | 32.69% | 22.17% | 10.29% | 4.24% | 4.89% | 1.64% | -6.67% | 1.21% | 1.42% | 1.50% |
NM % | -13.53% | 14.66% | 31.81% | 27.99% | 17.81% | 11.71% | 12.05% | 5.73% | -19.69% | 3.01% | 3.20% | 3.56% |
FCF / R% | 0.00% | -7.62% | -10.54% | -6.52% | -8.05% | -8.20% | -52.77% | -15.85% | 1.31% | -13.43% | 0.13% | -14.60% |
FCF / NI% | 2,737.40% | -51.98% | -33.14% | -23.44% | -47.45% | -75.15% | -437.40% | -312.19% | -6.33% | -451.49% | 3.91% | -385.00% |
Operating Margin (OM) | 0.00 | 0.12 | 0.15 | 0.37 | 0.59 | 0.52 | 0.48 | 0.55 | 0.38 | 0.31 | 0.32 | 0.35 |
Per Share
Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS | 0.00 | 0.00 | 2.07 | 2.34 | 1.26 | 0.88 | 1.19 | 0.32 | -1.05 | 0.21 | 0.25 | 0.25 |
SPS | 0.00 | 0.00 | 6.51 | 8.36 | 7.08 | 7.51 | 9.85 | 5.68 | 5.34 | 7.03 | 7.67 | 7.02 |
OCPS | 0.00 | 0.00 | 2.18 | 1.09 | 1.00 | 0.10 | -3.13 | 0.34 | 1.49 | 1.33 | 0.85 | -0.51 |
FCPS | 0.00 | 0.00 | -0.69 | -0.55 | -0.57 | -0.62 | -5.20 | -0.90 | 0.07 | -0.94 | 0.01 | -1.02 |
BVPS | 0.00 | 0.00 | 3.63 | 6.34 | 7.51 | 16.33 | 17.42 | 11.09 | 9.89 | 10.12 | 10.35 | 11.32 |
Per Share - CAGR
Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
CAGR-EPS | 0.00 | 0.00 | 2.07 | 2.34 | 1.26 | 0.88 | 1.19 | 0.32 | -1.05 | 0.21 | 0.25 | 0.25 |
CAGR-SPS | 0.00 | 0.00 | 6.51 | 8.36 | 7.08 | 7.51 | 9.85 | 5.68 | 5.34 | 7.03 | 7.67 | 7.02 |
CAGR-OCPS | 0.00 | 0.00 | 2.18 | 1.09 | 1.00 | 0.10 | -3.13 | 0.34 | 1.49 | 1.33 | 0.85 | -0.51 |
CAGR-FCPS | 0.00 | 0.00 | -0.69 | -0.55 | -0.57 | -0.62 | -5.20 | -0.90 | 0.07 | -0.94 | 0.01 | -1.02 |
CAGR-BVPS | 0.00 | 0.00 | 3.63 | 6.34 | 7.51 | 16.33 | 17.42 | 11.09 | 9.89 | 10.12 | 10.35 | 11.32 |